Alkermes (ALKS) Invested Capital (2010 - 2026)
Alkermes (ALKS) reported Invested Capital of $1.8 billion for Q1 2026, up 17.63% year-over-year from $1.5 billion in Q1 2025, and down 2.27% quarter-over-quarter from $1.8 billion in Q4 2025.
Alkermes (ALKS) Invested Capital (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Invested Capital data on file, last reported at $1.8 billion in Q1 2026.
- Invested Capital for Q1 2026 came in at $1.8 billion, up 17.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 17.63% YoY), and the FY2025 annual result was $1.8 billion, up 24.19% from the prior year.
- Invested Capital fell to $1.8 billion in Q1 2026 per ALKS's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Invested Capital peaked at $1.8 billion in Q4 2025 and troughed at $1.0 billion in Q1 2023.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2024 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2025: Invested Capital slipped 6.47% in 2023, then jumped 33.84% in 2025.
- A 5-year view of Invested Capital shows it stood at $1.0 billion in 2022, then climbed by 15.18% to $1.2 billion in 2023, then climbed by 21.51% to $1.5 billion in 2024, then grew by 24.19% to $1.8 billion in 2025, then retreated by 2.27% to $1.8 billion in 2026.
- Business Quant data shows ALKS's Invested Capital at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 479.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.79 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 108.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Bn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 1.73 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.46 Bn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.29 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.12 Bn |
| Sep 30, 2021 | 1.10 Bn |
| Jun 30, 2021 | 1.10 Bn |